STOCK TITAN
  1. Home
  2. Sec-filings
  3. LYRA
  4. [EFFECT] Lyra Therapeutics, Inc. SEC Filing

[EFFECT] Lyra Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 26, 2026
Accession Number: 0001193125-26-124481
Submission Type: POS AM
CIK: 0001327273
Company Name: Lyra Therapeutics, Inc.
File Number: 333-272981

Source: View Original Filing on SEC EDGAR

Lyra Therapeutics, Inc.

OTC:LYRA

View LYRA Stock Overview →

LYRA Rankings

#6934 Ranked by Market Cap
N/A Ranked by Dividends

LYRA Latest News

Jan 12, 2026
Lyra Therapeutics Provides Corporate Update
Nov 12, 2025
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Oct 6, 2025
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study
Aug 12, 2025
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Jun 27, 2025
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

LYRA Latest SEC Filings

Mar 27, 2026
[EFFECT] Lyra Therapeutics, Inc. SEC Filing
Mar 25, 2026
[POS AM] Lyra Therapeutics, Inc. SEC Filing
Mar 25, 2026
[POS AM] Lyra Therapeutics, Inc. SEC Filing
Mar 25, 2026
[POS AM] Lyra Therapeutics, Inc. SEC Filing
Mar 16, 2026
[8-K] Lyra Therapeutics, Inc. Reports Material Event

LYRA Stock Data

2.34M
1.76M
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
WATERTOWN